Full name
DR HERBICH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical substances
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
32 - Other manufacturing
86 - Human health activities
96 - Other personal service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -45,3 | 96,7 | 32,1 | -66,8 |
Gross profit (loss) | -45,3 | 96,7 | 28,3 | -70,8 |
EBITDA | -38,2 | 101,5 | 29,6 | -70,8 |
Short time liabilities | 95,4 | 55,5 | 101,6 | 83,1 |
Other operating costs | 0 | 0 | 5,8 | -∞ |
Equity capital | -8,2 | 76,7 | 101,7 | 32,6 |
Operating profit (EBIT) | -45,3 | 96,7 | 27,6 | -71,5 |
Assets | 87,2 | 132,2 | 203,3 | 53,8 |
Net profit (loss) | -45,3 | 84,9 | 25 | -70,5 |
Cash | 0 | 0,7 | 1,2 | 64 |
Net income from sale | 760,3 | 787,5 | 760 | -3,5 |
Liabilities and provisions for liabilities | 95,4 | 55,5 | 101,6 | 83,1 |
Working assets | 80,4 | 130,2 | 203,3 | 56,2 |
Other income costs | 0 | 0 | 1,3 | -∞ |
Depreciation | 7 | 4,8 | 2 | -58,3 |
% | % | % | p.p. | |
Profitability of capital | 551,5 | 110,7 | 24,6 | -86,1 |
Equity capital to total assets | -9,4 | 58 | 50 | -8 |
Gross profit margin | -6 | 12,3 | 3,7 | -8,6 |
EBITDA Margin | -5 | 12,9 | 3,9 | -9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 26 | 49 | 23 |
Current financial liquidity indicator | 0.8427556753158569 | 2.3470661640167236 | 2.001840591430664 | -0,3 |
Net dept to EBITDA | -0.01600748673081398 | -0.0073571037501096725 | -0.04137883707880974 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane